Hsieh, D., Chen, E. X., Franses, J. W., Feun, L. G., Hu, Z. I., King, G. T., Hwang, J. J., Stenehjem, D. D., Cunningham, C., Li, D. (2026). Tegavivint, a downstream Wnt/β-catenin inhibitor: Dose-finding results from a phase 1/2 trial in advanced hepatocellular carcinoma (aHCC).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4015